Symposia: Bone Marrow Failure: Acquired
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acquired Marrow Failure Syndromes, Clinical trials, MDS, Combination therapy, Fundamental Science, Bleeding and Clotting, Artificial intelligence (AI), Translational Research, Bone Marrow Failure Syndromes, CHIP, Assays, Aplastic Anemia, Genomics, Clinical Research, Genetic Disorders, Bioinformatics, Paroxysmal Nocturnal Hemoglobinuria, Hematopoiesis, Chronic Myeloid Malignancies, Thromboembolism, Diseases, Immune mechanism, Real-world evidence, Treatment Considerations, Immunology, Computational biology, Biological Processes, Myeloid Malignancies, Technology and Procedures, Machine learning, Pathology, Serologic Tests
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acquired Marrow Failure Syndromes, Clinical trials, MDS, Combination therapy, Fundamental Science, Bleeding and Clotting, Artificial intelligence (AI), Translational Research, Bone Marrow Failure Syndromes, CHIP, Assays, Aplastic Anemia, Genomics, Clinical Research, Genetic Disorders, Bioinformatics, Paroxysmal Nocturnal Hemoglobinuria, Hematopoiesis, Chronic Myeloid Malignancies, Thromboembolism, Diseases, Immune mechanism, Real-world evidence, Treatment Considerations, Immunology, Computational biology, Biological Processes, Myeloid Malignancies, Technology and Procedures, Machine learning, Pathology, Serologic Tests
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Room 11
(San Diego Convention Center)
Moderators:
Antonio M Risitano, MD, PhD, ARRAY(0xe591da8)
and
Bhavisha A. Patel, MD, National Institutes of Health
Disclosures:
No relevant conflicts of interest to declare.
This session will cover the most recent biological observation derived by the use of high-throughput technologies in patients suffering from acquired bone marrow failure syndromes. In particular, investigator will discuss data concerning TCR clonality, and its possibly relationship with causative antigen(s), the emergence of clonal hematopoiesis eventually tracked by somatic mutations, as well as genetic background which may shape the clinical presentation of a given disease
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH